NCT05259670 is a clinical trial in Intussusception, sponsored by Sanjeev Kharel.

Who is sponsoring NCT05259670?

NCT05259670 is sponsored by Sanjeev Kharel.

What condition does NCT05259670 study?

NCT05259670 studies Intussusception.

Is NCT05259670 still recruiting?

NCT05259670 is currently completed. Last updated 28 February 2022.

Last reviewed 2022-02-28 · How we verify

NCT05259670

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Risk Factors for Recurrent Intussusception Successful Reduction in Pediatric Patients

Completed Last updated 28 February 2022

What this trial tests

trial in Intussusception in 78 participants. Completed in 1 April 2020.

Timeline

1 June 2019

Primary endpoint
1 April 2020

1 April 2020

Quick facts

Lead sponsor	Sanjeev Kharel
Status	Completed
Study type	OBSERVATIONAL
Enrollment	78
Start date	1 June 2019
Primary completion	1 April 2020
Estimated completion	1 April 2020
Sites	2 locations across Nepal

Conditions studied

Intussusception — all drugs for Intussusception →

Sponsor

Sanjeev Kharel

Who can join

Adults 0 to 16, any sex, with Intussusception. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine risk factors associated with recurrent intussusception among pediatric patients who have undergone successful reduction at a tertiary care hospital.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Risk factors for recurrent intussusception after successful reduction in pediatric patients in a tertiary care hospital of Nepal: A prospective study.
Adhikari S, Koirala DP, Pokhrel RP, Dahal GR, et al · · 2022 · cited 3× · PMID 35495376 · DOI 10.1016/j.amsu.2022.103427

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05259670 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sanjeev Kharel
Last refreshed: 28 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05259670.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing